These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11078413)

  • 1. Hemodynamic and biochemical effects of endothelin-A- and -B-receptor antagonist TAK-044 in stroke-prone spontaneously hypertensive rats.
    Naruse M; Tanabe A; Naruse K; Adachi C; Yoshimoto T; Seki T; Takagi S; Imaki T; Watanabe T; Takano K
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S334-6. PubMed ID: 11078413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats: renal and hemodynamic effects of endothelin receptor antagonists.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S470-2. PubMed ID: 8587449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
    Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
    Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy.
    McDonald L; Lee GR; Degooyer TE; McDonald D; Canning P; Kelso EJ; McDermott BJ; Stitt AW
    Ophthalmic Res; 2010; 43(2):99-107. PubMed ID: 19829016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two calcium channel blockers on messenger RNA expression of endothelin-1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats.
    Naruse M; Tanabe A; Seki T; Adachi C; Yoshimoto T; Mishina N; Imaki T; Naruse K; Demura R; Demura H
    J Hypertens; 1999 Jan; 17(1):53-60. PubMed ID: 10100094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats.
    Girchev R; Bäcker A; Markova P; Kramer HJ
    Kidney Int; 2004 Mar; 65(3):982-9. PubMed ID: 14871418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats.
    Sharifi AM; He G; Touyz RM; Schiffrin EL
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S309-12. PubMed ID: 9595467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
    Jesmin S; Zaedi S; Maeda S; Togashi H; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):919-24. PubMed ID: 16741024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S160-4. PubMed ID: 15838270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy.
    Watanabe K; Ohta Y; Kouda T; Sekiguchi T; Sato S; Nakazawa M; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S49-54. PubMed ID: 11206720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the ET(A)/ET(B) antagonist, TAK-044, on blood pressure and renal excretory function after unclipping of conscious one-kidney-one-clip hypertensive rats.
    Bergström G; Nyström HC; Jia J; Evans RG
    J Hypertens; 2001 Mar; 19(3 Pt 2):659-65. PubMed ID: 11327643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S59-63. PubMed ID: 15838360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats.
    Touyz RM; Turgeon A; Schiffrin EL
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S300-4. PubMed ID: 11078404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of endothelin-1 and endothelial-type nitric oxide synthase in cardiovascular tissues of stroke-prone spontaneously hypertensive rats/Izm: effects of the angiotensin-converting enzyme inhibitor aracepril.
    Tanabe A; Naruse M; Seki T; Adachi C; Yoshimoto T; Imaki T; Naruse K; Demura R; Demura H
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S395-8. PubMed ID: 9595494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.